Currently, Autolus Therapeutics plc ADR’s (AUTL) stock is trading at $1.58, marking a fall of -4.24% from last night’s close. At this price, the stock is -66.31% below its 52-week high of $4.69 and 42.99% above its 52-week low of $1.11. Based on the past 30-day period, the stock price is -12.22% below the high and +8.97% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, AUTL’s SMA-200 is $1.8334.
As well, it is important to consider AUTL stock ratios such as price-to-sales, which is currently 13.93.AUTL’s price to book ratio for the most recent quarter was 1.62, resulting in an 0.92 price to cash per share for the period.
How does Autolus Therapeutics plc ADR (AUTL) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 10 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.70 in simple terms.
Autolus Therapeutics plc ADR (AUTL): Earnings History
If we examine Autolus Therapeutics plc ADR’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.18, slashing the consensus of -$0.23. In other words, it beat the consensus by $0.05, resulting in a 23.37% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.18 in contrast with the Outlook of -$0.23. That was a difference of $0.05 and a surprise of 23.37%.
Autolus Therapeutics plc ADR (AUTL): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 3 different analysts, who are expecting earnings to fall in between the range of -0.20 and -0.31 with an average Earnings Estimate of -0.24 which is in contrast with the last year earnings estimate of -0.31 and also replicates 22.58% growth rate year over year.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Ownership Details
I will give a breakdown of the key shareholders in Autolus Therapeutics plc ADR (AUTL). Recent figures show that the company’s insiders hold 18.09% of shares. A total of 121 institutional investors hold shares in the company, making 80.72% of its stock and 98.55% of its float.
Jul 31, 2025, it was reported that the Company’s largest institutional holder is VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund holding total of 19.36 shares that make 7.27% of the company’s total number of shares and are currently priced at 30.58 million.
The securities firm T. Rowe Price New Horizons Fund, Inc. holds 2.02 shares of AUTL, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.76%, and the holding percentage of shares is valued at 3.19 million.
An overview of Autolus Therapeutics plc ADR’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Autolus Therapeutics plc ADR (AUTL) traded 2,802,247 shares per day, with a moving average of $1.6275 and price change of -0.0500. With the moving average of $1.5470 and a price change of -0.3000, about 3,850,417 shares changed hands on average over the past 50 days. Finally, AUTL’s 100-day average volume is 3,007,932 shares, alongside a moving average of $1.9299 and a price change of -0.6800.
